Abstract:132 Purpose: Active inflammation is a risk factor predicting dissection or rupture of aortic aneurysm (AA). However, there is scarce method that can effectively assess inflammation in aortic wall of AA. The pre-targeted imaging strategy has advantages including excellent imaging contrast, low radiation exposure to normal organs, and suitability for short half-live radionuclide. The promising pre-targeted method is based on the biorthogonal click chemistry of inverse electron demand [4 + 2] Diels-Alder (IEDDA) cycloaddition between 1,2,4,5-terazine (Tz) and Trans-cyslooctene (TCO) alkene dienophile. The IEDDA has quick reaction rate with high efficiency but do not need catalyzer. In recent years, the IEDDA system showed its potential in the applications of in vivo tumor imaging, but has not been used in aortic imaging. The aim of this study was to investigate a novel pre-targeted single photon emission computed tomography (SPECT) imaging strategy (ant-CD11b-TCO/Tz-HYNIC-99mTc) for evaluating CD11b expression that was highly linked to inflammation in AA through the IEDDA system. Methods: A pre-targeted molecular detector, anti-CD11b-TCO, was synthesized and used for targeting inflammatory microenvironment of AA, and 99mTc-HYNIC-Tz, was created as imaging regent for SPECT/CT imaging. By using Raw-264.7 cell lines as positive cells and human umbilical vein endothelial cell (HUVEC) lines as negative counterparts, cell binging and relevant blocking test were performed to investigate affinity and specificity of the probe binding to inflammatory cells. C57BL/6J mice was fed with β-aminopropionitrile monofumarate (BAPN, 1g/kg/day) for 4 weeks to establish AA model. Then, anti-CD11b-TCO/Tz-HYNIC-99mTc pre-targeted SPECT/CT imaging were done to detect in-vivo inflammation in AA. Finally, ex vivo aortic breast specific gamma imaging (BSGI), and immunohistochemical staining were performed to confirm findings of in vivo SPECT/CT imaging. Results: The hybrid anti-CD11b-TCO presented with high TCO coupling ratio; and the 99mTc-HYNIC-Tz showed high radio-purity (> 95%), good in-vitro stability and a pharmacokinetics characteristic of quick clearance rate. Besides, anti-CD11b-TCO and 99mTc-HYNIC-Tz presented high conversion rate (~ 89%). The in-vitro clicked compound, 99mTc-HYNIC-Tz/TCO-anti-CD11b, showed high affinity and combining specificity with RAW-264.7 cells. The 99mTc-HYNIC-Tz/TCO-anti-CD11b pre-targeting SPECT/CT allows clear imaging inflammatory AA with high signal-to-normal ratio, which was significantly higher than those from AA mice that injected with 99mTc-HYNIC-Tz/TCO-IgG and C57BL/6J mice injected with 99mTc-HYNIC-Tz/TCO-anti-CD11b. This result was confirmed by in-vitro breast specific gamma imaging (BSGI) of corresponding aorta arteries right after SPECT/CT imaging and immunohistochemical staining of CD11b. Conclusions: SPECT/CT imaging using the pre-targeted strategy between anti-CD11b-TCO and 99mTc-HYNIC-Tz allows for detection of inflammation in the progressive AA.

CD11b-Based Pre-Targeted SPECT/CT Imaging Allows for the Detection of Inflammation in Aortic Aneurysm

Pretargeted SPECT/CT Imaging of CD11b Expression Allows for Detecting Instable Aorta Aneurysm That Full of Inflammation

99Mtc-Labelled Anti-Cd11b SPECT/CT Imaging Allows Detection of Plaque Destabilization Tightly Linked to Inflammation

PET Imaging of Abdominal Aortic Aneurysm with 64Cu-Labeled Anti-CD105 Antibody Fab Fragment.

A Dual Lock-and-key Probe for High-Fidelity Visualizing Abdominal Aortic Aneurysm-Related Inflammation Via a PET-TICT Integrated Near-Infrared Platform

CXCR4-targeted sensitive magnetic particle imaging for abdominal aortic aneurysm early detection and prognosis evaluation by recognizing total inflammatory cells

68Ga-labeled WVP peptide as a novel PET probe for molecular biological diagnosis of unstable thoracic aortic aneurysm and early dissection: an animal study

ICAM-1-carrying targeted nano contrast agent for evaluating inflammatory injury in rabbits with atherosclerosis

Preclinical Evaluation of a Novel 99Mtc-Labeled CB86 for Rheumatoid Arthritis Imaging.

Preclinical Evaluation of a Novel 99m Tc-Labeled CB86 for Rheumatoid Arthritis Imaging

Molecular imaging of atherosclerotic plaques with technetium-99m-labelled antisense oligonucleotides

Tissue factor detection for selectively discriminating unstable plaques in an atherosclerotic rabbit model

Ex vivo magnetic particle imaging of vascular inflammation in abdominal aortic aneurysm in a murine model

18F-PBR06 PET/CT Imaging for Evaluating Atherosclerotic Plaques Linked to Macrophage Infiltration

[Noninvasive Detection of Experimental Vulnerable Atherosclerotic Plaques with 99tc M Labeled C2A Domain of Synaptotagmin I].

Preparation and Evaluation of 99mtc‐labeled Anti‐cd11b Antibody Targeting Inflammatory Microenvironment for Colon Cancer Imaging

Specificity Evaluation and Disease Monitoring in Arthritis Imaging with Complement Receptor of the Ig superfamily targeting Nanobodies

Molecular Imaging of Inflammation in a Mouse Model of Atherosclerosis Using a Zirconium-89-Labeled Probe

99Mtc(co)3-Labeled 2-Phenylbenzothiazoles As Aβ Imaging Agents for the Detection of CAA

In vivo imaging of macrophages during the early-stages of abdominal aortic aneurysm using high resolution MRI in ApoE mice.

An increased major vessel uptake by 18F-FDG-PET/CT in NIH criteria inactive patients with Takayasu's arteritis.